Do mindfulness exercises improve patient experience during urodynamic testing?

ISRCTN ISRCTN17581455
DOI https://doi.org/10.1186/ISRCTN17581455
Secondary identifying numbers C.2016.202d-IRB approval number
Submission date
25/04/2018
Registration date
08/05/2018
Last edited
09/04/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Urodynamic study (UDS) is a series of tests that evaluate bladder and urethral function. UDS involves placing catheters into the bladder and rectum that can be uncomfortable. Several interventions have been attempted to reduce the unpleasantness associated with UDS without success. A new technique that has been shown to reduce chronic bladder pain is mindfulness. The aim of this study is to see whether incorporating mindfulness exercises before UDS results in less pain, anxiety and discomfort.

Who can participate?
Patients aged 18-80 scheduled to undergo UDS for urinary symptoms

What does the study involve?
Participants are randomly allocated to one of two treatment plans. One treatment plan includes undergoing mindfulness exercises before the UDS evaluation. Participants are guided through a mindfulness meditation exercise by a licensed professional where they are asked to focus their attention on their breathing, physical sensations, and thoughts. This exercise lasts for about 10 minutes and does not involve any physical activity other than sitting and breathing. The other treatment plan includes simply undergoing the UDS evaluation. After the UDS evaluation, participants are asked questions about their emotional and physical experiences during the UDS procedure, including pain, anxiety and discomfort.

What are the possible benefits and risks of participating?
Participants may experience less discomfort, anxiety and/or pain associated with UDS. There is no guarantee they will receive any benefit from this study other than knowing that the information may help future patients.

Where is the study run from?
Brooke Army Medical Center (USA)

When is the study starting and how long is it expected to run for?
September 2016 to April 2018

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Forrest Jellison

Contact information

Dr Forrest Jellison
Public

Division of Urology
3551 Roger Brooke Dr
Fort Sam Houston
78234
United States of America

Study information

Study designSingle-center randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleIncorporation of mindfulness exercises to reduce anxiety and pain during urodynamic testing: a pilot randomized controlled trial
Study hypothesisThe objective of the study is to investigate whether mindfulness techniques improve patient’s perceptions of UDS testing:
Objective 1: To evaluate changes in anxiety symptoms during UDS testing
Hypothesis: Anxiety will improve during UDS testing with prior mindfulness intervention
Objective 2: To evaluate changes in pain intensity during UDS testing
Hypothesis: Pain will improve during UDS testing with prior mindfulness intervention
Ethics approval(s)Regional Health Command-Central (RHC-C) Institutional Review Board, 29/09/2016, Protocol C.2016.202d
ConditionUrodynamic, urinary incontinence, anxiety, physical discomfort
InterventionThis a single center randomized trial with the urologist performing the urodynamic testing blinded or masked. Participants are randomly assigned to one of two treatment plans. One treatment plan includes undergoing mindfulness exercises prior to the UDS evaluation. Participants are guided through a mindfulness meditation exercise by a licensed professional where they are asked to focus their attention on their breathing, physical sensations, and thoughts. This exercise will last for approximately 10 minutes in which participants will not be asked to engage in any physical activity other than sitting and breathing. The other treatment plan includes simply undergoing the UDS evaluation. After the UDS evaluation, participants will be asked questions about the urodynamic procedure. They will be asked to answer questions on a UDS and anxiety questionnaire which pertain to their emotional and physical experiences during the procedure. They will rate the amount of discomfort on a scale of 1-10 during the procedure on a visual analog pain scale.
Intervention typeBehavioural
Primary outcome measureAnxiety as measured by state-trait anxiety inventory (STAI-6). The STAI-6 form consists of six feelings, negative feelings (tense, upset, worried) and positive feelings (calm, relaxed, content), that are measured with a Likert scale. Higher scores are associated with higher levels of anxiety. Measured three times during the same clinic visit for UDS testing: at baseline, about 10 min later, and after the UDS testing.
Secondary outcome measuresMeasured three times during the same clinic visit for UDS testing: at baseline, about 10 min later, and after the UDS testing:
1. Pain as measured on the visual analog scale
2. Emotional and physical discomfort as measured by a urodynamic questionnaire
Overall study start date29/09/2016
Overall study end date18/04/2018

Eligibility

Participant type(s)Patient
Age groupMixed
Lower age limit18 Years
Upper age limit80 Years
SexBoth
Target number of participants30
Total final enrolment27
Participant inclusion criteriaAdults (Department of Defense [DoD] beneficiaries and active duty military patients aged 18-80) scheduled for urodynamic testing
Participant exclusion criteria1. Age less than 18 years
2. Pregnant, as verified by urine or blood sample
3. Have an alteration in neurologic bladder function
4. Inability to complete forms
5. Inability to provide informed consent
Recruitment start date01/09/2017
Recruitment end date30/12/2018

Locations

Countries of recruitment

  • United States of America

Study participating centre

Brooke Army Medical Center
San Antonio
78234
United States of America

Sponsor information

Brooke Army Medical Center
Government

3551 Roger Brooke Dr
Fort Sam Houston
78234
United States of America

ROR logo "ROR" https://ror.org/00m1mwc36

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date30/04/2019
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryStored in repository
Publication and dissemination planPlan to submit for publication by June 2018.
IPD sharing planThe data that is stored is de-identified from the validated questionnaires and demographic information.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Basic results 09/04/2019 09/04/2019 No No

Additional files

ISRCTN17581455_BasicResults_09Apr19.pdf
Uploaded 09/04/2019

Editorial Notes

09/04/2019: The following changes were made to the trial record:
1. The total final enrolment number was added.
2. The basic results of this trial have been uploaded as an additional file.
3. The intention to publish date was changed from 01/06/2018 to 30/04/2019.
09/05/2018: Internal review.